vs
AppLovin Corp（APP）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是AppLovin Corp的1.1倍（$1.4B vs $1.3B），AppLovin Corp净利率更高（82.7% vs 3.6%，领先79.1%），通用电气医疗同比增速更快（12.2% vs -2.9%），过去两年通用电气医疗的营收复合增速更高（13.0% vs 12.2%）
AppLovin是总部位于美国加利福尼亚州帕洛阿尔托的移动科技公司，成立于2012年，旗下拥有SSP MAX、DSP AppDiscovery营销平台及SparkLabs创意工作室，可为开发者提供应用推广、变现、分析及发行服务，同时也对多家移动游戏发行商开展投资。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
APP vs OPCH — 直观对比
营收规模更大
OPCH
是对方的1.1倍
$1.3B
营收增速更快
OPCH
高出15.1%
-2.9%
净利率更高
APP
高出79.1%
3.6%
两年增速更快
OPCH
近两年复合增速
12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.4B |
| 净利润 | $1.1B | $51.8M |
| 毛利率 | 95.2% | 19.0% |
| 营业利润率 | — | 5.9% |
| 净利率 | 82.7% | 3.6% |
| 营收同比 | -2.9% | 12.2% |
| 净利润同比 | 84.0% | -3.8% |
| 每股收益（稀释后） | $3.24 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APPOPCH
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.2B | $1.3B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.1B |
净利润APPOPCH
| Q4 25 | $1.1B | — | ||
| Q3 25 | $835.5M | $51.8M | ||
| Q2 25 | $819.5M | $50.5M | ||
| Q1 25 | $576.4M | $46.7M | ||
| Q4 24 | $599.2M | $60.1M | ||
| Q3 24 | $434.4M | $53.9M | ||
| Q2 24 | $310.0M | $53.0M | ||
| Q1 24 | $236.2M | $44.8M |
毛利率APPOPCH
| Q4 25 | 95.2% | — | ||
| Q3 25 | 87.6% | 19.0% | ||
| Q2 25 | 87.7% | 19.0% | ||
| Q1 25 | 81.7% | 19.7% | ||
| Q4 24 | 76.7% | 21.3% | ||
| Q3 24 | 77.5% | 20.1% | ||
| Q2 24 | 73.8% | 20.3% | ||
| Q1 24 | 72.2% | 20.8% |
营业利润率APPOPCH
| Q4 25 | — | — | ||
| Q3 25 | 76.8% | 5.9% | ||
| Q2 25 | 76.1% | 5.8% | ||
| Q1 25 | 44.7% | 5.9% | ||
| Q4 24 | 44.3% | 6.9% | ||
| Q3 24 | 44.6% | 6.7% | ||
| Q2 24 | 36.2% | 6.6% | ||
| Q1 24 | 32.1% | 6.0% |
净利率APPOPCH
| Q4 25 | 82.7% | — | ||
| Q3 25 | 59.5% | 3.6% | ||
| Q2 25 | 65.1% | 3.6% | ||
| Q1 25 | 38.8% | 3.5% | ||
| Q4 24 | 43.6% | 4.8% | ||
| Q3 24 | 36.3% | 4.2% | ||
| Q2 24 | 28.7% | 4.3% | ||
| Q1 24 | 22.3% | 3.9% |
每股收益（稀释后）APPOPCH
| Q4 25 | $3.24 | — | ||
| Q3 25 | $2.45 | $0.32 | ||
| Q2 25 | $2.39 | $0.31 | ||
| Q1 25 | $1.67 | $0.28 | ||
| Q4 24 | $1.72 | $0.36 | ||
| Q3 24 | $1.25 | $0.31 | ||
| Q2 24 | $0.89 | $0.30 | ||
| Q1 24 | $0.67 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5B | $309.8M |
| 总债务越低越好 | $3.5B | $1.2B |
| 股东权益账面价值 | $2.1B | $1.4B |
| 总资产 | $7.3B | $3.5B |
| 负债/权益比越低杠杆越低 | 1.65× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资APPOPCH
| Q4 25 | $2.5B | — | ||
| Q3 25 | $1.7B | $309.8M | ||
| Q2 25 | $1.2B | $198.8M | ||
| Q1 25 | $551.0M | $171.4M | ||
| Q4 24 | $741.4M | $412.6M | ||
| Q3 24 | $567.6M | $483.0M | ||
| Q2 24 | $460.4M | $376.9M | ||
| Q1 24 | $436.3M | $219.5M |
总债务APPOPCH
| Q4 25 | $3.5B | — | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $3.5B | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
股东权益APPOPCH
| Q4 25 | $2.1B | — | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $575.4M | $1.4B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $938.2M | $1.4B | ||
| Q2 24 | $814.8M | $1.4B | ||
| Q1 24 | $760.2M | $1.4B |
总资产APPOPCH
| Q4 25 | $7.3B | — | ||
| Q3 25 | $6.3B | $3.5B | ||
| Q2 25 | $6.0B | $3.4B | ||
| Q1 25 | $5.7B | $3.3B | ||
| Q4 24 | $5.9B | $3.4B | ||
| Q3 24 | $5.4B | $3.4B | ||
| Q2 24 | $5.3B | $3.3B | ||
| Q1 24 | $5.3B | $3.2B |
负债/权益比APPOPCH
| Q4 25 | 1.65× | — | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | 3.22× | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $139.4M |
| 自由现金流经营现金流 - 资本支出 | — | $130.2M |
| 自由现金流率自由现金流/营收 | — | 9.1% |
| 资本支出强度资本支出/营收 | — | 0.6% |
| 现金转化率经营现金流/净利润 | 1.19× | 2.69× |
| 过去12个月自由现金流最近4个季度 | — | $220.7M |
8季度趋势，按日历期对齐
经营现金流APPOPCH
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.1B | $139.4M | ||
| Q2 25 | $772.2M | $90.3M | ||
| Q1 25 | $831.7M | $-7.2M | ||
| Q4 24 | $701.0M | $36.1M | ||
| Q3 24 | $550.7M | $160.4M | ||
| Q2 24 | $454.5M | $195.7M | ||
| Q1 24 | $392.8M | $-68.8M |
自由现金流APPOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | $130.2M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $-16.6M | ||
| Q4 24 | — | $25.8M | ||
| Q3 24 | — | $150.7M | ||
| Q2 24 | — | $185.9M | ||
| Q1 24 | — | $-74.6M |
自由现金流率APPOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | -6.5% |
资本支出强度APPOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.5% |
现金转化率APPOPCH
| Q4 25 | 1.19× | — | ||
| Q3 25 | 1.26× | 2.69× | ||
| Q2 25 | 0.94× | 1.79× | ||
| Q1 25 | 1.44× | -0.15× | ||
| Q4 24 | 1.17× | 0.60× | ||
| Q3 24 | 1.27× | 2.98× | ||
| Q2 24 | 1.47× | 3.69× | ||
| Q1 24 | 1.66× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APP
| Other | $673.9M | 51% |
| US | $659.0M | 49% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
